摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[(4-acetyl-2-methoxyphenoxy)methyl]-N-benzyloxycarbonyl-1-aminocyclopropane | 1245794-02-8

中文名称
——
中文别名
——
英文名称
1-[(4-acetyl-2-methoxyphenoxy)methyl]-N-benzyloxycarbonyl-1-aminocyclopropane
英文别名
benzyl N-[1-[(4-acetyl-2-methoxyphenoxy)methyl]cyclopropyl]carbamate
1-[(4-acetyl-2-methoxyphenoxy)methyl]-N-benzyloxycarbonyl-1-aminocyclopropane化学式
CAS
1245794-02-8
化学式
C21H23NO5
mdl
——
分子量
369.417
InChiKey
AZYZEIAPFXEOJT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    27
  • 可旋转键数:
    9
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    73.9
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-[(4-acetyl-2-methoxyphenoxy)methyl]-N-benzyloxycarbonyl-1-aminocyclopropane 以56的产率得到1-[(4-acetyl-2-methoxy-5-nitrophenoxy)methyl]-N-benzyloxycarbonyl-1-aminocyclopropane
    参考文献:
    名称:
    Process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide and synthetic intermediates thereof
    摘要:
    本发明涉及一种制备化合物6-(7-4(1-氨基环丙基)甲氧基)-6-甲氧基喹啉-4-氧基)-N-甲基-1-萘酰胺(I)及其药学上可接受的盐的高产率和纯度的方法。该方法相较于先前描述的方法具有各种优点,特别是避免了酰基叠氮中间体及其Curtius重排的使用。还描述了用于制备化合物(I)的新型中间体。
    公开号:
    US08642767B2
  • 作为产物:
    描述:
    Cbz-1-氨基环丙烷甲醇香草乙酮 以53.5的产率得到1-[(4-acetyl-2-methoxyphenoxy)methyl]-N-benzyloxycarbonyl-1-aminocyclopropane
    参考文献:
    名称:
    Process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide and synthetic intermediates thereof
    摘要:
    本发明涉及一种制备化合物6-(7-4(1-氨基环丙基)甲氧基)-6-甲氧基喹啉-4-氧基)-N-甲基-1-萘酰胺(I)及其药学上可接受的盐的高产率和纯度的方法。该方法相较于先前描述的方法具有各种优点,特别是避免了酰基叠氮中间体及其Curtius重排的使用。还描述了用于制备化合物(I)的新型中间体。
    公开号:
    US08642767B2
点击查看最新优质反应信息

文献信息

  • Process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide and synthetic intermediates thereof
    申请人:Spinelli Silvano
    公开号:US08642767B2
    公开(公告)日:2014-02-04
    A process for the preparation in high yields and purity of the compound 6-(7-4(1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide of formula (I) and of the pharmaceutically acceptable salts thereof is described. The process has various advantages over those previously described, in particular it avoids the use of acyl azide intermediates and their Curtius rearrangement. Novel intermediates useful for the preparation of compound (I) are also described.
    本发明涉及一种制备化合物6-(7-4(1-氨基环丙基)甲氧基)-6-甲氧基喹啉-4-氧基)-N-甲基-1-萘酰胺(I)及其药学上可接受的盐的高产率和纯度的方法。该方法相较于先前描述的方法具有各种优点,特别是避免了酰基叠氮中间体及其Curtius重排的使用。还描述了用于制备化合物(I)的新型中间体。
  • PROCESS FOR THE PREPARATION OF 6-(7-((1-AMINOCYCLOPROPYL)METHOXY)-6-METHOXYQUINOLIN-4-YLOXY)-N-METHYL-1-NAPHTHAMIDE AND SYNTHETIC INTERMEDIATES THEREOF
    申请人:Spinelli Silvano
    公开号:US20120010415A1
    公开(公告)日:2012-01-12
    A process for the preparation in high yields and purity of the compound 6-(7-4(1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide of formula (I) and of the pharmaceutically acceptable salts thereof is described. The process has various advantages over those previously described, in particular it avoids the use of acyl azide intermediates and their Curtius rearrangement. Novel intermediates useful for the preparation of compound (I) are also described.
    本发明描述了一种制备化合物6-(7-4(1-氨基环丙基)甲氧基)-6-甲氧基喹啉-4-氧基)-N-甲基-1-萘酰胺(I)及其药学上可接受的盐的高产率和高纯度的方法。该方法相对于以前描述的方法具有各种优点,特别是避免了使用酰基叠氮中间体及其Curtius重排反应。还描述了用于制备化合物(I)的新型中间体。
  • Process for the Preparation of 6-(7-((1-Aminocyclopropyl)Methoxy)-6-Methoxyquinolin-4-Yloxy)-N-Methyl-1-Naphthamide and Synthetic Intermediates Thereof
    申请人:Clovis Oncology Italy S.r.l.
    公开号:US20150191429A1
    公开(公告)日:2015-07-09
    A process for the preparation in high yields and purity of the compound 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide of formula (I) and of the pharmaceutically acceptable salts thereof is described. The process has various advantages over those previously described, in particular it avoids the use of acyl azide intermediates and their Curtius rearrangement. Novel intermediates useful for the preparation of compound (I) are also described.
    本发明提供了一种制备式(I)化合物及其药学上可接受的盐的高产率和高纯度的方法。该方法与先前描述的方法相比具有各种优点,特别是它避免了使用酰基叠氮中间体及其Curtius重排。还描述了用于制备化合物(I)的新型中间体。
  • A process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide and synthetic intermediates thereof
    申请人:EOS Ethical Oncology Science S.p.A. in abbreviated form EOS S.p.A.
    公开号:EP2641897A2
    公开(公告)日:2013-09-25
    A process for the preparation in high yields and purity of the compound 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide of formula (I) and of the pharmaceutically acceptable salts thereof is described. The process has various advantages over those previously described, in particular it avoids the use of acyl azide intermediates and their Curtius rearrangement. Novel intermediates useful for the preparation of compound (I) are also described.
    本发明描述了一种高产率、高纯度制备式(I)化合物 6-(7-((1-氨基环丙基)甲氧基)-6-甲氧基喹啉-4-氧基)-N-甲基-1-萘甲酰胺及其药学上可接受的盐类的工艺。与之前描述的工艺相比,该工艺具有各种优点,尤其是避免了使用酰基叠氮化物中间体及其 Curtius 重排。此外,还描述了用于制备化合物 (I) 的新型中间体。
  • INTERMEDIATES FOR THE PREPARATION OF 6-(7-((1-AMINOCYCLOPROPYL)METHOXY)-6-METHOXYQUINOLIN-4-YLOXY)-N-METHYL-1-NAPHTHAMIDE
    申请人:Clovis Oncology Italy S.r.l.
    公开号:EP3103792A1
    公开(公告)日:2016-12-14
    A process for the preparation in high yields and purity of the compound 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide of formula (I) and of the pharmaceutically acceptable salts thereof is described. The process has various advantages over those previously described, in particular it avoids the use of acyl azide intermediates and their Curtius rearrangement. Novel intermediates useful for the preparation of compound (I) are also described.
    本发明描述了一种高产率、高纯度制备式(I)化合物 6-(7-((1-氨基环丙基)甲氧基)-6-甲氧基喹啉-4-氧基)-N-甲基-1-萘甲酰胺及其药学上可接受的盐类的工艺。与之前描述的工艺相比,该工艺具有各种优点,尤其是避免了使用酰基叠氮化物中间体及其 Curtius 重排。此外,还描述了用于制备化合物 (I) 的新型中间体。
查看更多